693 related articles for article (PubMed ID: 20098724)
1. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
Fowkes FJ; Richards JS; Simpson JA; Beeson JG
PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
[TBL] [Abstract][Full Text] [Related]
2. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder M; Sutherland CJ; Sisay-Joof F; Ismaili J; McCall MB; Ord R; Hallett R; Holder AA; Milligan P
Infect Immun; 2006 May; 74(5):2887-93. PubMed ID: 16622227
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
[TBL] [Abstract][Full Text] [Related]
6. Antibody Correlates of Protection from Clinical
Hamre KES; Ondigo BN; Hodges JS; Dutta S; Theisen M; Ayodo G; John CC
Am J Trop Med Hyg; 2020 Dec; 103(6):2174-2182. PubMed ID: 33124533
[TBL] [Abstract][Full Text] [Related]
7. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
[TBL] [Abstract][Full Text] [Related]
11. Identification of a potent combination of key Plasmodium falciparum merozoite antigens that elicit strain-transcending parasite-neutralizing antibodies.
Pandey AK; Reddy KS; Sahar T; Gupta S; Singh H; Reddy EJ; Asad M; Siddiqui FA; Gupta P; Singh B; More KR; Mohmmed A; Chitnis CE; Chauhan VS; Gaur D
Infect Immun; 2013 Feb; 81(2):441-51. PubMed ID: 23184525
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia.
Mamo H; Esen M; Ajua A; Theisen M; Mordmüller B; Petros B
Malar J; 2013 Feb; 12():51. PubMed ID: 23383869
[TBL] [Abstract][Full Text] [Related]
13. Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria.
Kana IH; Singh SK; Garcia-Senosiain A; Dodoo D; Singh S; Adu B; Theisen M
J Infect Dis; 2019 Jun; 220(2):275-284. PubMed ID: 30820557
[TBL] [Abstract][Full Text] [Related]
14. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.
Osier FH; Fegan G; Polley SD; Murungi L; Verra F; Tetteh KK; Lowe B; Mwangi T; Bull PC; Thomas AW; Cavanagh DR; McBride JS; Lanar DE; Mackinnon MJ; Conway DJ; Marsh K
Infect Immun; 2008 May; 76(5):2240-8. PubMed ID: 18316390
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Antigens Derived from
Pratt-Riccio LR; De Souza Perce-Da-Silva D; Da Costa Lima-Junior J; Pratt Riccio EK; Ribeiro-Alves M; Santos F; Arruda M; Camus D; Druilhe P; Oliveira-Ferreira J; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2017 Nov; 97(5):1581-1592. PubMed ID: 29016339
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.
Yman V; White MT; Asghar M; Sundling C; Sondén K; Draper SJ; Osier FHA; Färnert A
BMC Med; 2019 Jan; 17(1):22. PubMed ID: 30696449
[TBL] [Abstract][Full Text] [Related]
18. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.
Soe S; Theisen M; Roussilhon C; Aye KS; Druilhe P
Infect Immun; 2004 Jan; 72(1):247-52. PubMed ID: 14688102
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.
McCarra MB; Ayodo G; Sumba PO; Kazura JW; Moormann AM; Narum DL; John CC
Pediatr Infect Dis J; 2011 Dec; 30(12):1037-42. PubMed ID: 21817955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
